Answers are grounded in this paper and cite their sources.
Cytochrome P450 3A4 (CYP3A4) contributes to the clearance of more than 30% of marketed drugs and exhibits substantial inter-individual variability. The classical kinetic descriptors Km and Vmax, derived from Michaelis-Menten (MM) fitting, are routinely used to characterize ligand-induced perturbation of enzymatic activity. However, when a compound modulates Km and Vmax in a discordant or concentration-dependent manner, univariate analysis becomes ambiguous and the distinction between genuine mixed-type modulation and unstable parameter fitting is not formally addressed by standard practice. This work introduces a geometric framework in which the kinetic state of the enzyme is represented as a point in the (Km, Vmax) parameter space, and ligand-induced modulation as a displacement of that point. From this representation a set of synthetic indices is derived; the joint behaviour of these indices is then used both to characterize the type of modulation (activation, inhibition, mixed) and to provide an internal consistency criterion for the underlying kinetic parameters. The framework is applied retrospectively to a panel of eight CYP3A4 ligands tested on midazolam 1-hydroxylation in human liver microsomes, covering the full spectrum of known modulator behaviours and including historically difficult cases such as efavirenz. This document is deposited as a working paper to establish priority of the methodological idea. A complete peer-reviewed manuscript with full mathematical formalization, error propagation analysis, and extended dataset is in preparation.
No takes yet. Share an insight, caveat, or question.
Jonathan Salerno (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: